「by」の検索結果
76件：16～20件目を表示
-
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in Japan, effective immediately (medical device a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
eutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for ImageFS” in Japan. MIEr for ImageFS...
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126.pdf -
学会发表 | 研究与开发 | 千寿制药株式会社
orado, United States of America Motugivatrep suppresses the expression of proinflammatory mediators by inhibiting TRPV1 activation mediated by hyperosmotic and inflammatory stimuli in human corneal ep...
http://www.senju.co.jp/chinese/rd/society/ -
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in Japan, effective immediately (medical device a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for dry-eye analysis in Japan as an option of RE...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf